Clara Alcon
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Flow cytometry analysis of mitochondrial apoptotic priming with BH3 profiling on senescent cells.
Journal: Methods in cell biology
Published: September 03, 2026
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 03, 2025
HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells.
Journal: Cell death and differentiation
Published: June 14, 2024
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer.
Journal: Cell death & disease
Published: February 21, 2024
Dual inhibition of MEK and PI3Kβ/δ-a potential therapeutic strategy in PTEN-wild-type docetaxel-resistant metastatic prostate cancer.
Journal: Frontiers in pharmacology
Published: November 01, 2023
BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma.
Journal: Neuro-oncology
Published: August 17, 2022
MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatment.
Journal: Cell death discovery
Published: November 04, 2021
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
Journal: Cells
Published: May 31, 2021
Cell Line-Specific Network Models of ER+ Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations.
Journal: Cancer research
Published: April 16, 2021
MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic Leukemia.
Journal: Frontiers in cell and developmental biology
Published: April 14, 2021
Last Updated: 09/26/2026